Heinz Schmidli
123 works · 4,139 citations · h-index 36
Top works
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts
- Application of Artificial Neural Networks (ANN) in the Development of Solid Dosage Forms
- Population pharmacokinetics of imatinib mesylate in patients with chronic‐phase chronic myeloid leukaemia: results of a phase III study
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations
- Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form
- Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients
- Basic Concepts of Artificial Neural Networks (ANN) Modeling in the Application to Pharmaceutical Development
- Safety, Tolerability, and Efficacy of Everolimus in De Novo Liver Transplant Recipients: 12- and 36-Month Results
- The Effects of a Flexible Visual Acuity–Driven Ranibizumab Treatment Regimen in Age-Related Macular Degeneration: Outcomes of a Drug and Disease Model
- Everolimus Therapeutic Concentration Range Defined from a Prospective Trial with Reduced-Exposure Cyclosporine in De Novo Kidney Transplantation
- Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage form
- Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design
- Estimands and Their Role in Clinical Trials
- Therapeutic Drug Monitoring for Everolimus in Heart Transplant Recipients Based on Exposure–Effect Modeling
- Therapeutic drug monitoring for everolimus in kidney transplantation using 12‐month exposure, efficacy, and safety data
- Beyond Randomized Clinical Trials: Use of External Controls
- Rivastigmine exposure provided by a transdermal patch versus capsules
- Bayesian Design of Proof-of-Concept Trials
- Predictively consistent prior effective sample sizes